Form 3 - Initial statement of beneficial ownership of securities

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

Neuehealth (NYSE:NEUE)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Neuehealth Charts.

Neuehealth (NYSE:NEUE)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Neuehealth Charts.

Neuehealth Inc News

Form 3 - Initial statement of beneficial ownership of securities
Saturday 4 January 2025 (3 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

NeueHealth to Be Taken Private by NEA and Consortium of Investors
Tuesday 24 December 2024 (2 weeks ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 24 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 24 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Neuehealth Reports Third Quarter 2024 Results
Thursday 7 November 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Wednesday 30 October 2024 (2 months ago) • Edgar (US Regulatory)

NeueHealth Acquires Full Ownership of Centrum Health
Wednesday 30 October 2024 (2 months ago) • Business Wire

NeueHealth to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024
Thursday 17 October 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 9 October 2024 (3 months ago) • Edgar (US Regulatory)

More Neuehealth Inc News Articles

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions